SCHEMBL2575425

SCHEMBL2575425

CCOC(=O)CC1CC2(CCN(C(=O)C(CCCc3ccccc3)NC(=O)C(C)(C)N)CC2)c2ccccc21

nearest known ligand 0.46

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 1/20 0.46
HSD11B1 P28845 3/20 0.41
HSD11B2 P80365 1/20 0.41
CCKBR P32239 2/20 0.39
OPRK1 P41145 6/20 0.38
SIGMAR1 Q99720 1/20 0.38
TACR1 P25103 2/20 0.37
ACE P12821 1/20 0.35
ALDH1A1 P00352 2/20 0.35
MEN1 O00255 1/20 0.35
LMNA P02545 1/20 0.35
KMT2A Q03164 1/20 0.35
TACR2 P21452 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2579092 1.00 GHSR (0.46) GHSRHSD11B1HSD11B2CCKBROPRK1
SCHEMBL2577149 1.00 GHSR (0.46) GHSRHSD11B1HSD11B2CCKBROPRK1
SCHEMBL2575426 1.00 GHSR (0.46) GHSRHSD11B1HSD11B2CCKBROPRK1
SCHEMBL5615551 1.00 GHSR (0.46) GHSRHSD11B1HSD11B2CCKBROPRK1
Hydrochloric Acid SCHEMBL8315713 0.99 GHSR (0.45) GHSRHSD11B1HSD11B2CCKBROPRK1
Hydrochloric Acid SCHEMBL8315714 0.99 GHSR (0.45) GHSRHSD11B1HSD11B2CCKBROPRK1
SCHEMBL2579165 0.93 GHSR (0.45) GHSRHSD11B1HSD11B2CCKBROPRK1
SCHEMBL2579166 0.93 GHSR (0.45) GHSRHSD11B1HSD11B2CCKBROPRK1
SCHEMBL5615867 0.93 GHSR (0.45) GHSRHSD11B1HSD11B2CCKBROPRK1
Hydrochloric Acid SCHEMBL8313866 0.92 GHSR (0.44) GHSRHSD11B1HSD11B2CCKBROPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0662481-B1 Spiro piperidines and homologs promote release of growth hormone MERCK & CO INC (US) 1999-03-24 EP claimed
US-5578593-A RELEASING GROWTH HORMONES FOR ANIMALS MERCK & CO., INC. (US) 1996-11-26 US claimed
EP-0662481-A1 Spiro piperidines and homologs promote release of growth hormone MERCK & CO. INC. (US) 1995-07-12 EP claimed
EP-2389941-A1 Growth-hormone secretagogues Elixir Pharmaceuticals, Inc. (US) 2011-11-30 EP disclosed
US-20080261873-A1 Growth-Hormone Secretagogues ELIXIR PHARMACEUTICALS, INC. (US) 2008-10-23 US disclosed
EP-0662481-B1 Spiro piperidines and homologs promote release of growth hormone MERCK & CO INC (US) 1999-03-24 EP disclosed
US-5578593-A RELEASING GROWTH HORMONES FOR ANIMALS MERCK & CO., INC. (US) 1996-11-26 US disclosed
EP-0662481-A1 Spiro piperidines and homologs promote release of growth hormone MERCK & CO. INC. (US) 1995-07-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080261873-A1 Growth-Hormone Secretagogues GHSR, GHRHR, GIPR GHSR 1/4885HSD11B1 449/4885HSD11B2 339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.